CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Oral supplement A +4 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03707652
NCT03707652N/ACompleted
CompareCT.gov

Three-Day Dosing NAD + Study

Supplement Formulators, Inc.·interventional·Posted Oct 16, 2018·Updated Oct 18, 2018

In Brief

A clinical study evaluating Oral supplement A, Oral supplement B, and 3 other interventions for Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+). Completed, enrolled 8 participants across 1 site.

Detailed Summary

The purpose of this study is to assess an effective single oral supplement or combination of oral supplements for increasing whole blood NAD+ levels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIncrease in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+)
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 16, 2018
Enrollment StartMar 12, 2018
Primary CompletionMay 16, 2018
Study CompletionMay 24, 2018
TodayJul 1, 2026
Enrollment to primary: 2 monthsPosted 7.7 years ago

Interventions

Oral supplement Adietary

1, 2 or 4 capsules daily of oral supplement A for 3 days

Oral supplement Bdietary

4 capsules daily of oral supplement B for 3 days

Oral supplement Cdietary

1,2 or 4 capsules daily of oral supplement C for 3 days

Oral supplement Ddietary

1 or 2 tablets daily of oral supplement D for 3 days

Oral Supplement D in combination with oral supplement Cdietary

1 or 2 tablets of oral supplement D in combination with 2 or 4 capsules of oral supplement C for 3 days